Astec Lifesciences Ltd. | Cash Flow
Fiscal year is April-March. All values INR Thousands.
2014
2015
2016
2017
2018
Net Income before Extraordinaries
86,516.00
147,825.90
124,242.00
287,431.00
557,116.00
Depreciation, Depletion & Amortization
147,672.00
126,873.00
103,984.00
136,819.00
146,815.00
Other Funds
10,821.00
14,763.90
-
-
-
Funds from Operations
241,002.00
291,368.90
153,441.00
449,696.00
481,742.00
Changes in Working Capital
138,855.00
230,892.00
387,524.00
375,863.00
63,726.00
Net Operating Cash Flow
102,147.00
60,476.90
234,083.00
73,833.00
545,468.00
Capital Expenditures
190,390.00
201,076.20
260,377.00
208,886.00
496,957.00
Sale of Fixed Assets & Businesses
-
1,022.20
-
3,935.00
-
Purchase/Sale of Investments
441.00
472.10
5,100.00
-
-
Net Investing Cash Flow
189,949.00
200,526.00
179,837.00
204,952.00
496,957.00
Cash Dividends Paid - Total
21,678.00
21,678.20
29,297.00
-
35,235.00
Issuance/Reduction of Debt, Net
79,596.00
151,967.10
464,121.00
110,983.00
42,594.00
Net Financing Cash Flow
81,107.00
215,525.00
434,824.00
112,948.00
75,847.00
Net Change in Cash
6,695.00
75,475.90
20,904.00
18,171.00
27,336.00
Free Cash Flow
71,062.00
98,612.00
494,460.00
135,053.00
48,511.00
Other Sources
-
-
75,440.00
-
-
Change in Capital Stock
12,368.00
99,999.90
-
1,965.00
1,982.00
About Astec Lifesciences
View Profile
